Ambu A/S (AMBBY)
12.84
+0.23
(+1.82%)
USD |
OTCM |
Feb 20, 16:00
Ambu EPS Diluted (Quarterly) : 0.0686 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Genmab A/S | 0.0461 |
| Ascendis Pharma A/S | -0.6364 |
| Zealand Pharma A/S | -0.8368 |
| Bavarian Nordic A/S | 0.7287 |
| ALK-Abello A/S | 0.2219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 18.39M |
| Revenue (Quarterly) | 242.81M |
| Total Expenses (Quarterly) | 224.42M |
| Enterprise Value | 3.377B |
| Gross Profit Margin (Quarterly) | 60.78% |
| Profit Margin (Quarterly) | 7.57% |
| Earnings Yield | 2.38% |
| Operating Earnings Yield | 3.09% |
| Normalized Earnings Yield | 2.382 |